ABT(ABT)
ABT
Product Revenue Segments
Latest: 2025 (2025-12-31) · Total: $44.31B
| Segment | Revenue | Share |
|---|---|---|
Medical Devices | $21.39B | 48.3% |
Diagnostic Products | $8.94B | 20.2% |
Nutritional Products | $8.45B | 19.1% |
Established Pharmaceutical Products | $5.54B | 12.5% |
Other | $0 | 0.0% |
Geographic Revenue Segments
Latest: 2025 (2025-12-31) · Total: $42.99B
| Segment | Revenue | Share |
|---|---|---|
UNITED STATES | $17.13B | 39.8% |
Non-US | $15.98B | 37.2% |
D [E] | $2.76B | 6.4% |
C [N] | $1.91B | 4.4% |
I [N] | $1.87B | 4.4% |
C [H] | $1.87B | 4.4% |
J [P] | $1.48B | 3.4% |
Other | $0 | 0.0% |
Source: SEC filings via FMP · Last updated May 25, 2026